Baca berita tanpa iklan. Gabung Kompas.com+
Indonesia Approves Sinovac Covid-19 Vaccine for Emergency Use in Children Aged 6 to 11
The authorization was based on the evaluation of phase 2 clinical trials that the immunogenicity of the Sinovac vaccine reached 96.5 percent.
Back to article...
Comment wisely and responsibly. Comments are entirely the responsibility of the commentator as regulated in the ITE Law
Report
Thank You! We have received your report. We will remove comments that conflict with the Community Guidelines and the ITE Law.

More headlines

News
April 14, 2023, 12.38 PM

Indonesia Detects New Covid Arcturus Variant

Baca berita tanpa iklan. Gabung Kompas.com+
Baca berita tanpa iklan. Gabung Kompas.com+
COMMENTS

MOST POPULAR

Baca berita tanpa iklan. Gabung Kompas.com+
Baca berita tanpa iklan. Gabung Kompas.com+
Close Ads